Episodes 151-165 of 617
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Project Oncology®Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Project Oncology®Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Project Oncology®Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Project Oncology®The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Project Oncology®Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®Addressing Health Equity in Genitourinary Cancer Clinical Trials
Treating mCRPC After Progression: The Potential Role of 225Ac-J591
Project Oncology®Treating mCRPC After Progression: The Potential Role of 225Ac-J591
mCRPC Care: Predicting Response to Radium-223 Treatment with a PET Scan
Project Oncology®mCRPC Care: Predicting Response to Radium-223 Treatment with a PET Scan
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®An Exploration of Current and Emerging Therapies for mCRPC
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Project Oncology®NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Inflammatory Breast Cancer: A New Scoring System Proposed
Project Oncology®Inflammatory Breast Cancer: A New Scoring System Proposed
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Project Oncology®SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
